NCT06607185 2026-03-13A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting750 enrolled
NCT00313599 2014-07-02Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsUniversity of California, San FranciscoPhase 1 Completed28 enrolled